Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,259 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Sale · Disposed 2,236 · Balance 8,970 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2025-03-03 · Sale · Disposed 1,233 · Balance 7,737 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2025-03-03 · Sale · Disposed 478 · Balance 7,259 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectHeld by son | 167 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 167 |
| Common StockSEC Table I · non-derivative | IndirectHeld by daughter | 166 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 166 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 24, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167 Read SEC document |
| April 23, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 166 Read SEC document |
| April 23, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 167 Read SEC document |
| April 23, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367 Read SEC document |
| April 23, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533 Read SEC document |
| April 15, 2019 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,400 | $52.52 | $73,528.00 |
DisclosureSEC source: 0001104659-19-020313 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.30 to $52.75. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,600 | $51.57 | $443,502.00 |
DisclosureSEC source: 0001104659-19-020313 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,374 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.30 to $52.23. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11 | $51.75 | $569.25 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,404 | $50.69 | $71,168.76 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.55 to $51.05. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,585 | $50.11 | $179,644.35 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,389 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $50.54. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,300 | $52.05 | $119,715.00 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.77 to $52.53. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,300 | $53.01 | $121,923.00 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,274 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.63 to $53.54. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 200 | $54.12 | $10,824.00 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,574 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.64 to $54.60. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 200 | $56.37 | $11,274.00 |
DisclosureSEC source: 0001104659-19-019725 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Sr VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,774 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,390 Underlying: Common Stock · 5,000 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,055 | $49.09 | $100,879.95 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.98 to $49.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,945 | $48.54 | $142,950.30 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,029 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.97 to $48.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,000 | $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · derivative · entry 8 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,390 Underlying: Common Stock · 5,000 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,440 | $48.95 | $119,438.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.63 to $49.40. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,960 | $48.23 | $94,530.80 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,414 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.63 to $48.53. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 600 | $46.90 | $28,140.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,374 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.61 to $47.42. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,000 | $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-002130 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2018 Filed Jan 4, 2019 22:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-19-000848 · a4.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-12-18 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 18, 2018 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 100 | $41.32 | $4,132.00 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 8 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,632 | $40.56 | $66,197.51 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,074 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.23 to $41.22. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,268 | $39.61 | $129,440.25 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $ 40.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,390 Underlying: Common Stock · 10,000 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 300 | $43.04 | $12,912.00 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 300 | $42.24 | $12,670.50 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,274 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.98 to $ $42.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,244 | $41.04 | $92,096.00 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,574 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.68 to $ $41.30. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,156 | $40.02 | $86,290.67 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.51 to $ $40.50. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $1.47 | $14,700.00 |
DisclosureSEC source: 0001104659-18-069597 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 10, 2018 00:40 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 900 | $16.00 | $14,400.00 |
DisclosureSEC source: 0001104659-18-031843 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,974 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.